ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 19 filers reported holding ADMA BIOLOGICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $8,901,000 | +37.7% | 1,433,304 | 0.0% | 99.96% | +0.1% |
| Q2 2018 | $6,464,000 | -2.0% | 1,433,304 | 0.0% | 99.88% | +0.1% |
| Q1 2018 | $6,593,000 | +43.3% | 1,433,304 | 0.0% | 99.80% | +1848.5% |
| Q4 2017 | $4,601,000 | +4.2% | 1,433,304 | 0.0% | 5.12% | +2.2% |
| Q3 2017 | $4,415,000 | -16.7% | 1,433,304 | 0.0% | 5.01% | -42.3% |
| Q2 2017 | $5,303,000 | -24.2% | 1,433,304 | 0.0% | 8.68% | -31.5% |
| Q1 2017 | $6,995,000 | -4.7% | 1,433,304 | 0.0% | 12.68% | -16.6% |
| Q4 2016 | $7,339,000 | -29.3% | 1,433,304 | 0.0% | 15.19% | +10.6% |
| Q3 2016 | $10,377,000 | +11.6% | 1,433,304 | 0.0% | 13.73% | +15.1% |
| Q2 2016 | $9,302,000 | -19.8% | 1,433,304 | 0.0% | 11.94% | -25.1% |
| Q1 2016 | $11,595,000 | +0.2% | 1,433,304 | 0.0% | 15.93% | +13.2% |
| Q4 2015 | $11,567,000 | – | 1,433,304 | – | 14.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |